Rockefeller Capital Management’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-12,150
| Closed | -$286K | – | 1660 |
|
|
2024
Q4 | $286K | Buy |
12,150
+1,439
| +13% | +$33.9K | ﹤0.01% | 1603 |
|
|
2024
Q3 | $274K | Sell |
10,711
-1,139
| -10% | -$29.2K | ﹤0.01% | 1554 |
|
|
2024
Q2 | $278K | Sell |
11,850
-2,135
| -15% | -$50.1K | ﹤0.01% | 1564 |
|
|
2024
Q1 | $402K | Sell |
13,985
-6,273
| -31% | -$180K | ﹤0.01% | 1528 |
|
|
2023
Q4 | $665K | Buy |
20,258
+2,584
| +15% | +$84.8K | ﹤0.01% | 1268 |
|
|
2023
Q3 | $492K | Buy |
17,674
+2,341
| +15% | +$65.2K | ﹤0.01% | 1290 |
|
|
2023
Q2 | $523K | Sell |
15,333
-1,306
| -8% | -$44.5K | ﹤0.01% | 1325 |
|
|
2023
Q1 | $500K | Sell |
16,639
-534
| -3% | -$16K | ﹤0.01% | 1353 |
|
|
2022
Q4 | $484K | Sell |
17,173
-334,991
| -95% | -$9.44M | ﹤0.01% | 1297 |
|
|
2022
Q3 | $11.6M | Buy |
352,164
+39,386
| +13% | +$1.29M | 0.06% | 321 |
|
|
2022
Q2 | $9.85M | Buy |
312,778
+296,251
| +1,793% | +$9.33M | 0.05% | 352 |
|
|
2022
Q1 | $758K | Buy |
16,527
+3,817
| +30% | +$175K | ﹤0.01% | 1157 |
|
|
2021
Q4 | $777K | Sell |
12,710
-2,104
| -14% | -$129K | ﹤0.01% | 1144 |
|
|
2021
Q3 | $1.11M | Buy |
14,814
+455
| +3% | +$34K | 0.01% | 966 |
|
|
2021
Q2 | $1.33M | Sell |
14,359
-2,649
| -16% | -$245K | 0.01% | 828 |
|
|
2021
Q1 | $1.51M | Buy |
17,008
+5,471
| +47% | +$485K | 0.01% | 658 |
|
|
2020
Q4 | $1.08M | Buy |
11,537
+4,248
| +58% | +$396K | 0.01% | 675 |
|
|
2020
Q3 | $464K | Buy |
+7,289
| New | +$464K | ﹤0.01% | 812 |
|